Literature DB >> 30820591

[Periprosthetic fractures of the acetabulum and femur : Causes-classification-treatment algorithms].

D M Ates1, P Koenen1, R Otchwemah1, H Bäthis2.   

Abstract

BACKGROUND: Both increasing implantation numbers of total hip replacements and demographic change with higher populations of older people, indicate that there will be an increase in periprosthetic fractures in the future. CAUSES: Falls in the home environment are the most common cause. Significant co-factors include reduced patient coordination, reduced bone quality, or implant-associated factors such as local osteolysis or pre-existing implant loosening. CLASSIFICATION: In the classification of periprosthetic fractures of the femur, the Vancouver classification has prevailed in recent years, which in addition to a description of the localization of the fracture also considers the stability of the prosthesis and bone quality. Based on this, therapeutic algorithms have been developed that can vary from the conservative approach via osteosynthetic options to a replacement of the prosthesis. In order to allow the description of periprosthetic fractures on all joints, the Vancouver classification has been extended to the UCS classification by including the AO/OTA bone and joint coding system. In the selection of the treatment method, the consideration of individual patient factors such as activity level and secondary diagnoses is essential. Based on the established classifications, the importance of the different therapeutic methods is presented.

Entities:  

Keywords:  Osteolysis; Osteosynthesis; Revision surgery; Total hip replacement; Vancouver classification

Mesh:

Year:  2019        PMID: 30820591     DOI: 10.1007/s00132-019-03696-8

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  49 in total

1.  The reliability and validity of the Vancouver classification of femoral fractures after hip replacement.

Authors:  O H Brady; D S Garbuz; B A Masri; C P Duncan
Journal:  J Arthroplasty       Date:  2000-01       Impact factor: 4.757

Review 2.  Proximal femoral replacement with megaprosthesis.

Authors:  A L Malkani; J M Paiso; F H Sim
Journal:  Instr Course Lect       Date:  2000

3.  Outcome following stabilization of type B1 periprosthetic femoral fractures.

Authors:  Sanjeev Agarwal; C M Andrews; G M Bakeer
Journal:  J Arthroplasty       Date:  2005-01       Impact factor: 4.757

4.  Treatment protocol for proximal femoral periprosthetic fractures.

Authors:  Javad Parvizi; Venkat R Rapuri; James J Purtill; Peter F Sharkey; Richard H Rothman; William J Hozack
Journal:  J Bone Joint Surg Am       Date:  2004       Impact factor: 5.284

5.  Fracture of the greater trochanter after hip replacement.

Authors:  J W Pritchett
Journal:  Clin Orthop Relat Res       Date:  2001-09       Impact factor: 4.176

6.  Fixation of periprosthetic femoral shaft fractures occurring at the tip of the stem: a biomechanical study of 5 techniques.

Authors:  M G Dennis; J A Simon; F J Kummer; K J Koval; P E DiCesare
Journal:  J Arthroplasty       Date:  2000-06       Impact factor: 4.757

7.  Periprosthetic femoral fractures classification and demographics of 1049 periprosthetic femoral fractures from the Swedish National Hip Arthroplasty Register.

Authors:  Hans Lindahl; Henrik Malchau; Peter Herberts; Göran Garellick
Journal:  J Arthroplasty       Date:  2005-10       Impact factor: 4.757

Review 8.  Periprosthetic fractures evaluation and treatment.

Authors:  Bassam A Masri; R M Dominic Meek; Clive P Duncan
Journal:  Clin Orthop Relat Res       Date:  2004-03       Impact factor: 4.176

Review 9.  Periprosthetic fractures of the acetabulum associated with a total hip arthroplasty.

Authors:  Craig J Della Valle; Nathan G Momberger; Wayne G Paprosky
Journal:  Instr Course Lect       Date:  2003

10.  [Titanium modular revision prosthesis stem in revision hip prosthesis].

Authors:  A Schuh; U Holzwarth; G Zeiler
Journal:  Orthopade       Date:  2004-01       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.